Low Daily Step Counts Linked to Slower Alzheimer’s Progression
A study followed nearly 300 older adults who had early Alzheimer’s-related brain changes for nine to 11 years using pedometers. Greater physical activity was linked to less tau buildup in specific brain regions and about half the decline in cognition and daily function, with benefits beginning near 3,000 steps and leveling off at 5,000 to 7,500 steps. The research did not find a reduction in amyloid plaques and had limitations, including a small, mostly white and well-educated sample.
The study followed roughly 300 older participants who already showed early Alzheimer’s-related brain changes, using pedometers for nine to 11 years. Activity did not appear to lower amyloid plaques, the protein deposits many treatments target. Instead, among those with plaques, movement was tied to less misfolded tau in certain brain regions. Tau emerges later and tracks more closely with losses in thinking and daily functioning, which were nearly halved in the more active group.
Benefits began around 3,000 steps—about 30 minutes of moderate walking—and plateaued at 5,000 to 7,500. The sample was small, mostly white, well-educated, and US-based, and other lifestyle or health factors were not fully considered.
This finding could encourage older adults, especially those who are sedentary or daunted by 10,000-step goals, to view modest walking as potentially brain-protective. Clinicians and public health messaging may emphasize achievable activity targets, while researchers could investigate whether exercise directly slows tau-related decline or mainly reflects healthier lifestyles. Because the study sample was limited, step counts may not be a guaranteed prevention strategy; broader, more diverse research may clarify who benefits most.